Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel A Freedman

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
Current Oncology Reports|September 29, 2015
Treatment of Breast Cancer in the ElderlyRachel A Freedman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2017
Emerging Data and Current Challenges for Young, Old, Obese, or Male Patients with Breast CancerRachel A Freedman, Ann H Partridge
JAMA|July 29, 2020
Menopausal Hormone Therapy and Long-term Breast Cancer Risk: Further Data From the Women's Health Initiative TrialsChristina A Minami, Rachel A Freedman
Journal of the National Cancer Institute|May 13, 2011
Family cancer history: healthy skepticism requiredRachel A Freedman, Judy E Garber
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2019
Who Are the Patients in Our Clinical Trials for Cancer?Rachel A Freedman, Kathryn J Ruddy
Journal of the National Cancer Institute|October 16, 2019
Adjuvant Chemotherapy for Older Patients With Breast Cancer: When Is the Pain Worth the Gain?Rachel A Freedman, Eric P Winer
Journal of Geriatric Oncology|February 4, 2014
Managing metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer in the older patientRachel A Freedman, Hyman B Muss
Breast (Edinburgh, Scotland)|October 1, 2013
Management of breast cancer in very young womenRachel A Freedman, Ann H Partridge
Breast (Edinburgh, Scotland)|October 22, 2011
Adjuvant therapies for very young women with early stage breast cancerRachel A Freedman, Ann H Partridge
Breast Cancer Research and Treatment|November 6, 2017
Efficacy and safety in older patient subsets in studies of endocrine monotherapy versus combination therapy in patients with HR+/HER2- advanced breast cancer: a reviewRachel A Freedman, Sara M Tolaney
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Current Oncology Reports|September 29, 2015
Treatment of Breast Cancer in the ElderlyRachel A Freedman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2017
Emerging Data and Current Challenges for Young, Old, Obese, or Male Patients with Breast CancerRachel A Freedman, Ann H Partridge
JAMA|July 29, 2020
Menopausal Hormone Therapy and Long-term Breast Cancer Risk: Further Data From the Women's Health Initiative TrialsChristina A Minami, Rachel A Freedman
Journal of the National Cancer Institute|May 13, 2011
Family cancer history: healthy skepticism requiredRachel A Freedman, Judy E Garber
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2019
Who Are the Patients in Our Clinical Trials for Cancer?Rachel A Freedman, Kathryn J Ruddy
Journal of the National Cancer Institute|October 16, 2019
Adjuvant Chemotherapy for Older Patients With Breast Cancer: When Is the Pain Worth the Gain?Rachel A Freedman, Eric P Winer
Journal of Geriatric Oncology|February 4, 2014
Managing metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer in the older patientRachel A Freedman, Hyman B Muss
Breast (Edinburgh, Scotland)|October 1, 2013
Management of breast cancer in very young womenRachel A Freedman, Ann H Partridge
Breast (Edinburgh, Scotland)|October 22, 2011
Adjuvant therapies for very young women with early stage breast cancerRachel A Freedman, Ann H Partridge
Breast Cancer Research and Treatment|November 6, 2017
Efficacy and safety in older patient subsets in studies of endocrine monotherapy versus combination therapy in patients with HR+/HER2- advanced breast cancer: a reviewRachel A Freedman, Sara M Tolaney
Pageof 17